The present invention is directed to polypeptides and compositions thereof useful for the prevention of treatment of allergic disorders, in particular atopic asthma. More particularly, the invention relates to tolerogenic agents and compositions thereof that useful for the prevention and treatment of hypersensitivity to allergens, in particular and/or strategies of desensitization to allergens.